Flynn Jodi, Harrison Kathryn, Le Viet
Dr. Flynn is with United Way Volunteer Care Clinic in Utah County, Utah, and Novartis Pharmaceuticals Company in East Hanover, New Jersey.
Dr. Harrison is with Forefront Dermatology in Englewood, Colorado.
J Clin Aesthet Dermatol. 2025 Jul-Aug;18(7-8 Suppl 1):S10-S15.
Hidradenitis suppurativa (HS) is a poorly recognized chronic skin condition that presents with inflamed recurring painful nodules, abscesses, and subcutaneous tunnels, mainly impacting intertriginous areas. Although extensively studied for its dermatological implications, recent research suggests a potential correlation between HS and cardiovascular disease. Studies reveal a heightened prevalence of cardiovascular risk factors, such as obesity, metabolic syndrome, and smoking, in individuals with HS. Most researchers attribute HS's elevated cardiovascular risk to these coexisting factors.
This review aims to identify whether or not HS's underlying chronic inflammatory nature can contribute to atherosclerosis development, thereby elevating the risk of cardiovascular events and, specifically, major adverse cardiovascular events (MACE). Recognizing the association between HS and cardiovascular disease is crucial for comprehensive patient care.
A PubMed search was performed to locate clinical trials, systematic reviews, and clinical reviews published to date concerning this topic.
This review consolidates existing literature on the topic, summarizing key findings and emphasizing the need for further research to clarify the mechanisms linking HS and cardiovascular conditions and delineating best clinical practices to mitigate risk.
Many publications attribute the increase in cardiovascular disease to comorbid risk factors. Despite limited research on cardiovascular (CV) risk in patients with HS, emerging evidence indicates an increased risk of adverse CV outcomes in this population, consistent with data from other chronic inflammatory diseases indicating that the inflammatory nature of the disease itself is elevating cardiovascular events. More clinical research is needed to strengthen this hypothesis and improve patient outcomes.
An integrated, multidisciplinary approach combining dermatological and cardiovascular perspectives is vital for optimizing patient care and navigating the complexities of managing HS and its associated cardiovascular comorbidities.
化脓性汗腺炎(HS)是一种认识不足的慢性皮肤疾病,表现为反复出现的炎性疼痛性结节、脓肿和皮下隧道,主要累及皮肤褶皱部位。尽管对其皮肤学影响已进行了广泛研究,但最近的研究表明HS与心血管疾病之间可能存在关联。研究显示,HS患者中肥胖、代谢综合征和吸烟等心血管危险因素的患病率较高。大多数研究人员将HS心血管风险升高归因于这些并存因素。
本综述旨在确定HS潜在的慢性炎症性质是否会促进动脉粥样硬化的发展,从而增加心血管事件尤其是主要不良心血管事件(MACE)的风险。认识到HS与心血管疾病之间的关联对于全面的患者护理至关重要。
在PubMed上进行检索,以查找迄今为止发表的有关该主题的临床试验、系统评价和临床综述。
本综述整合了该主题的现有文献,总结了主要发现,并强调需要进一步研究以阐明HS与心血管疾病之间的联系机制,并确定降低风险的最佳临床实践。
许多出版物将心血管疾病的增加归因于合并的危险因素。尽管关于HS患者心血管(CV)风险的研究有限,但新出现的证据表明该人群不良CV结局的风险增加,这与其他慢性炎症性疾病的数据一致,表明疾病本身的炎症性质会增加心血管事件。需要更多的临床研究来强化这一假设并改善患者结局。
结合皮肤科和心血管科观点的综合、多学科方法对于优化患者护理以及应对HS及其相关心血管合并症管理的复杂性至关重要。